These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

897 related articles for article (PubMed ID: 25104089)

  • 21. Targeting invadopodia for blocking breast cancer metastasis.
    Meirson T; Gil-Henn H
    Drug Resist Updat; 2018 Jul; 39():1-17. PubMed ID: 30075834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translational research in oncology--10 years of progress and future prospects.
    Doroshow JH; Kummar S
    Nat Rev Clin Oncol; 2014 Nov; 11(11):649-62. PubMed ID: 25286976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NF-κB signaling in cancer stem cells: a promising therapeutic target?
    Vazquez-Santillan K; Melendez-Zajgla J; Jimenez-Hernandez L; Martínez-Ruiz G; Maldonado V
    Cell Oncol (Dordr); 2015 Oct; 38(5):327-39. PubMed ID: 26318853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent developments in targeting carbonic anhydrase IX for cancer therapeutics.
    McDonald PC; Winum JY; Supuran CT; Dedhar S
    Oncotarget; 2012 Jan; 3(1):84-97. PubMed ID: 22289741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translational modeling and simulation approaches for molecularly targeted small molecule anticancer agents from bench to bedside.
    Yamazaki S; Spilker ME; Vicini P
    Expert Opin Drug Metab Toxicol; 2016; 12(3):253-65. PubMed ID: 26799750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets.
    Wood SL; Pernemalm M; Crosbie PA; Whetton AD
    Cancer Treat Rev; 2014 May; 40(4):558-66. PubMed ID: 24176790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCR9 in cancer: oncogenic role and therapeutic targeting.
    Tu Z; Xiao R; Xiong J; Tembo KM; Deng X; Xiong M; Liu P; Wang M; Zhang Q
    J Hematol Oncol; 2016 Feb; 9():10. PubMed ID: 26879872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting PAK1.
    Semenova G; Chernoff J
    Biochem Soc Trans; 2017 Feb; 45(1):79-88. PubMed ID: 28202661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RAC1: an emerging therapeutic option for targeting cancer angiogenesis and metastasis.
    Bid HK; Roberts RD; Manchanda PK; Houghton PJ
    Mol Cancer Ther; 2013 Oct; 12(10):1925-34. PubMed ID: 24072884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitric oxide in cancer metastasis.
    Cheng H; Wang L; Mollica M; Re AT; Wu S; Zuo L
    Cancer Lett; 2014 Oct; 353(1):1-7. PubMed ID: 25079686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in understanding the complexities of metastasis.
    Chitty JL; Filipe EC; Lucas MC; Herrmann D; Cox TR; Timpson P
    F1000Res; 2018; 7():. PubMed ID: 30135716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer, signal transduction and nanotechnology.
    Sengupta P; Basu S; Sengupta S
    Curr Drug Deliv; 2011 May; 8(3):254-60. PubMed ID: 21291374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel therapeutic targets for cancer metastasis.
    Stoletov K; Beatty PH; Lewis JD
    Expert Rev Anticancer Ther; 2020 Feb; 20(2):97-109. PubMed ID: 31997674
    [No Abstract]   [Full Text] [Related]  

  • 34. A novel co-drug of aspirin and ursolic acid interrupts adhesion, invasion and migration of cancer cells to vascular endothelium via regulating EMT and EGFR-mediated signaling pathways: multiple targets for cancer metastasis prevention and treatment.
    Tang Q; Liu Y; Li T; Yang X; Zheng G; Chen H; Jia L; Shao J
    Oncotarget; 2016 Nov; 7(45):73114-73129. PubMed ID: 27683033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of apoptosis pathways in cancer stem cells.
    Fulda S
    Cancer Lett; 2013 Sep; 338(1):168-73. PubMed ID: 22429999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Pathways: Clinical Applications and Future Direction of Insulin-like Growth Factor-1 Receptor Pathway Blockade.
    Iams WT; Lovly CM
    Clin Cancer Res; 2015 Oct; 21(19):4270-7. PubMed ID: 26429980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The biological framework: translational research from bench to clinic.
    Yarden Y
    Oncologist; 2010; 15 Suppl 5():1-7. PubMed ID: 21138950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted Therapies in Melanoma: Translational Research at Its Finest.
    Ho AW; Tsao H
    J Invest Dermatol; 2015 Aug; 135(8):1929-1933. PubMed ID: 26174532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune Regulation of the Metastatic Process: Implications for Therapy.
    de Mingo Pulido A; Ruffell B
    Adv Cancer Res; 2016; 132():139-63. PubMed ID: 27613132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The axis of evil in the fight against cancer.
    Petrushev B; Tomuleasa C; Suşman S; Sorişău O; Aldea M; Kacsó G; Buigă R; Irimie A
    Rom J Intern Med; 2011; 49(4):319-25. PubMed ID: 22568277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.